These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36210141)

  • 1. Anti-Carbamylated Protein Antibodies, Tumour Necrosis Factor Alpha and Insulin Resistance in Egyptian Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    El Hawary MS; Hassan SA; ELatty SA; Khalil NM
    Reumatol Clin (Engl Ed); 2022 Oct; 18(8):469-474. PubMed ID: 36210141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Carbamylated Protein Antibodies, Tumour Necrosis Factor Alpha and Insulin Resistance in Egyptian Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    El Hawary MS; Hassan SA; ELatty SA; Khalil NM
    Reumatol Clin (Engl Ed); 2021 Jul; ():. PubMed ID: 34266801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
    Chung CP; Oeser A; Solus JF; Gebretsadik T; Shintani A; Avalos I; Sokka T; Raggi P; Pincus T; Stein CM
    Arthritis Rheum; 2008 Jul; 58(7):2105-12. PubMed ID: 18576352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity.
    Li Y; Jia R; Liu Y; Tang S; Ma X; Shi L; Zhao J; Hu F; Li Z
    Lupus; 2020 Mar; 29(3):239-247. PubMed ID: 31930936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of anti-carbamylated fibrinogen antibodies in systemic lupus erythematosus].
    Li YN; Xiang XH; Zhao J; Li Y; Sun F; Wang HY; Jia RL; Hu FL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1019-1024. PubMed ID: 31848497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.
    Ziegelasch M; van Delft MA; Wallin P; Skogh T; Magro-Checa C; Steup-Beekman GM; Trouw LA; Kastbom A; Sjöwall C
    Arthritis Res Ther; 2016 Dec; 18(1):289. PubMed ID: 27912793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
    Elsayed SA; Esmail MA; Ali RM; Mohafez OM
    Clin Rheumatol; 2019 Oct; 38(10):2683-2689. PubMed ID: 31161487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus.
    Tso TK; Huang WN
    Rheumatol Int; 2009 May; 29(7):735-42. PubMed ID: 19037607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement.
    Massaro L; Ceccarelli F; Colasanti T; Pendolino M; Perricone C; Cipriano E; Natalucci F; Capalbo G; Lucchetti R; Pecani A; Vomero M; Mancini R; Spinelli FR; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Jan; 27(1):105-111. PubMed ID: 28592200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can anticarbamylated protein antibodies be used to support the diagnosis of systemic lupus erythematosus?
    Özdemir B; Erden A; Erten Ş; Yeşil TH; Alışık M; Kucuksahin O
    Biomark Med; 2021 Oct; 15(14):1253-1260. PubMed ID: 34488432
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
    Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
    Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus.
    Quevedo-Abeledo JC; Sánchez-Pérez H; Tejera-Segura B; de Armas-Rillo L; Ojeda S; Erausquin C; González-Gay MÁ; Ferraz-Amaro I
    J Rheumatol; 2021 Mar; 48(3):339-347. PubMed ID: 32541071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of insulin resistance and beta-cell function by the homeostasis model assessment in patients with systemic lupus erythematosus.
    Tso TK; Huang HY; Chang CK; Liao YJ; Huang WN
    Clin Rheumatol; 2004 Oct; 23(5):416-20. PubMed ID: 15459813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Rosenau BJ; Schur PH
    J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.
    Stagakis I; Bertsias G; Karvounaris S; Kavousanaki M; Virla D; Raptopoulou A; Kardassis D; Boumpas DT; Sidiropoulos PI
    Arthritis Res Ther; 2012 Jun; 14(3):R141. PubMed ID: 22691241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
    Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
    Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
    Ceccarelli F; Perricone C; Colasanti T; Massaro L; Cipriano E; Pendolino M; Natalucci F; Mancini R; Spinelli FR; Valesini G; Conti F; Alessandri C
    Arthritis Res Ther; 2018 Jun; 20(1):126. PubMed ID: 29898764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.